Cart
Free US shipping over $10
Proud to be B-Corp

Advances in Clinical Chemistry Summary

Advances in Clinical Chemistry: Volume 112 by Gregory S. Makowski (Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USA)

Advances in Clinical Chemistry, Volume 112 highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Heterogeneity in Major Depressive Disorder: The need for Biomarker-based and Personalized Treatments, Advances in exosome analysis, Translational Proteomics and Phosphoproteomics: Tissue to Extracellular Vesicles, Immune Checkpoint Therapy, Tumor Immunology, and Biomarkers in Non-Small-Cell Lung Cancer, Advances in Congestive Heart Failure Biomarkers, Fluid biomarkers in Alzheimer's disease, and more.

About Gregory S. Makowski (Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USA)

Dr Gregory S Makowski is a board certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in his joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President and Chief Scientific Officer for Clinical Laboratory Partners in Newington CT, USA.

Table of Contents

Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments Shayam Suseelan and Graziano Pinna Advances in exosome analysis Arnau Pallares-Rusinol, Mireia Bernuz, Silio Lima Moura, Carolina Fernandez-Senac, Rosanna Rossi, Merce Marti, and Maria Isabel Pividori Translational proteomics and phosphoproteomics: Tissue to extracellular vesicles Xiaofeng Wu, Anton B. Iliuk, and W. Andy Tao Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers Koji Kurose, Kanako Sakaeda, Minoru Fukuda, Yumiko Sakai, Hiroyuki Yamaguchi, Shinnosuke Takemoto, Katsuhiko Shimizu, Takeshi Masuda, Katsumi Nakatomi, Shigeo Kawase, Ryo Tanaka, Takayuki Suetsugu, Keiko Mizuno, Takehiro Hasegawa, Yusuke Atarashi, Yasuhiro Irino, Toshiyuki Sato, Hiromasa Inoue, Noboru Hattori, Eiichiro Kanda, Masao Nakata, Hiroshi Mukae, Toru Oga, and Mikio Oka Advances in congestive heart failure biomarkers Iyyapu Krishna Mohan, K.S.S. Sai Baba, Rohit Iyyapu, Sunitha Thirumalasetty, and O. Sai Satish Fluid biomarkers in Alzheimer's disease Joel Simr

Additional information

NPB9780443192845
9780443192845
0443192847
Advances in Clinical Chemistry: Volume 112 by Gregory S. Makowski (Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USA)
New
Hardback
Elsevier Science Publishing Co Inc
2023-01-11
304
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time

Customer Reviews - Advances in Clinical Chemistry